News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
“Magic” Mushroom Compound Eases Depression
Tanya Lewis | May 17, 2016
Psilocybin led to an improvement in symptoms for treatment-resistant patients, according to a small study.
Zooming In on an Antidepressant Target
Ruth Williams | Apr 6, 2016
Structural studies reveal how SSRI drugs bind to the human serotonin transporter.
A Genetic Root to Seasonal Affective Disorder
Bob Grant | Feb 23, 2016
Researchers have identified a gene that ties sleeping patterns to the winter blues experienced by many people living at extreme northern and southern latitudes.
Antidepressant Exerts Epigenetic Changes
Anna Azvolinsky | Nov 25, 2015
Molecular markers could aid researchers’ assessment of patient response to the drug.
Amanda B. Keener | Sep 1, 2015
Researchers explore the benefits of hearing loss and impairment.
Genetic Variants Linked to Depression
Amanda B. Keener | Jul 20, 2015
Researchers link variations in two genes to cases of major depressive disorder in two large cohorts.
Magic Mushroom Dreams
Jef Akst | Jul 3, 2014
A psychedelic compound in hallucinogenic mushrooms triggers brain activity characteristic of dream states.
Week in Review: April 14–18
Tracy Vence | Apr 18, 2014
Genome-wide effects of trisomy 21; RNA-based signs of transgenerational stress; depression and resilience; a call to overhaul US biomedical research system
Triggering Resilience to Depression
Ed Yong | Apr 17, 2014
In mice, boosting depression-causing activity in neurons can actually reverse depressive symptoms.
Depression Biomarker Found
Bob Grant | Feb 19, 2014
Researchers identify elevated levels of a stress hormone in teenage boys as a signpost of major depression.